BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32954656)

  • 1. C-Cbl regulates c-MPL receptor trafficking and its internalization.
    Märklin M; Tandler C; Kopp HG; Hoehn KL; Quintanilla-Martinez L; Borst O; Müller MR; Saur SJ
    J Cell Mol Med; 2020 Nov; 24(21):12491-12503. PubMed ID: 32954656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation.
    Ng AP; Kauppi M; Metcalf D; Hyland CD; Josefsson EC; Lebois M; Zhang JG; Baldwin TM; Di Rago L; Hilton DJ; Alexander WS
    Proc Natl Acad Sci U S A; 2014 Apr; 111(16):5884-9. PubMed ID: 24711413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.
    Lebois M; Dowling MR; Gangatirkar P; Hodgkin PD; Kile BT; Alexander WS; Josefsson EC
    J Thromb Haemost; 2016 Sep; 14(9):1882-7. PubMed ID: 27344013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitination and degradation of the thrombopoietin receptor c-Mpl.
    Saur SJ; Sangkhae V; Geddis AE; Kaushansky K; Hitchcock IS
    Blood; 2010 Feb; 115(6):1254-63. PubMed ID: 19880496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pronounced thrombocytosis in transgenic mice expressing reduced levels of Mpl in platelets and terminally differentiated megakaryocytes.
    Tiedt R; Coers J; Ziegler S; Wiestner A; Hao-Shen H; Bornmann C; Schenkel J; Karakhanova S; de Sauvage FJ; Jackson CW; Skoda RC
    Blood; 2009 Feb; 113(8):1768-77. PubMed ID: 18845793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete restoration of Mpl expression in the mpl-/- mouse produces partial correction of the stem cell-repopulating defect and paradoxical thrombocytosis.
    Lannutti BJ; Epp A; Roy J; Chen J; Josephson NC
    Blood; 2009 Feb; 113(8):1778-85. PubMed ID: 18796624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.
    Bender M; Giannini S; Grozovsky R; Jönsson T; Christensen H; Pluthero FG; Ko A; Mullally A; Kahr WH; Hoffmeister KM; Falet H
    Blood; 2015 Feb; 125(6):1014-24. PubMed ID: 25468568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developmental Stage-Specific Manifestations of Absent TPO/c-MPL Signalling in Newborn Mice.
    Lorenz V; Ramsey H; Liu ZJ; Italiano J; Hoffmeister K; Bihorel S; Mager D; Hu Z; Slayton WB; Kile BT; Sola-Visner M; Ferrer-Marin F
    Thromb Haemost; 2017 Dec; 117(12):2322-2333. PubMed ID: 29212120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YRRL motifs in the cytoplasmic domain of the thrombopoietin receptor regulate receptor internalization and degradation.
    Hitchcock IS; Chen MM; King JR; Kaushansky K
    Blood; 2008 Sep; 112(6):2222-31. PubMed ID: 18487512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombopoietin (TPO) induces thrombocytic colony formation of kidney cells synergistically with kit ligand A and a non-secretory TPO variant exists in common carp.
    Katakura F; Sugie Y; Hayashi K; Nishiya K; Miyamae J; Okano M; Nakanishi T; Moritomo T
    Dev Comp Immunol; 2018 Jul; 84():327-336. PubMed ID: 29522790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.
    Tong W; Lodish HF
    J Exp Med; 2004 Sep; 200(5):569-80. PubMed ID: 15337790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the c-Mpl thrombopoietin receptor through gene disruption and activation.
    Alexander WS; Roberts AW; Maurer AB; Nicola NA; Dunn AR; Metcalf D
    Stem Cells; 1996; 14 Suppl 1():124-32. PubMed ID: 11012212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin.
    Cohen-Solal K; Vitrat N; Titeux M; Vainchenker W; Wendling F
    Blood; 1999 May; 93(9):2859-66. PubMed ID: 10216080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential in vivo roles of Mpl cytoplasmic tyrosine residues in murine hematopoiesis and myeloproliferative disease.
    Behrens K; Kauppi M; Viney EM; Kueh AJ; Hyland CD; Willson TA; Salleh L; de Graaf CA; Babon JJ; Herold MJ; Nicola NA; Alexander WS
    Leukemia; 2024 Jun; 38(6):1342-1352. PubMed ID: 38491305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombopoietin stimulates colony-forming unit-megakaryocyte proliferation and megakaryocyte maturation independently of cytokines that signal through the gp130 receptor subunit.
    Broudy VC; Lin NL; Fox N; Taga T; Saito M; Kaushansky K
    Blood; 1996 Sep; 88(6):2026-32. PubMed ID: 8822921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombopoietin from beginning to end.
    Hitchcock IS; Kaushansky K
    Br J Haematol; 2014 Apr; 165(2):259-68. PubMed ID: 24499199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Mpl receptor expressed on endothelial cells does not contribute significantly to the regulation of circulating thrombopoietin levels.
    Geddis AE; Fox NE; Kaushansky K
    Exp Hematol; 2006 Jan; 34(1):82-6. PubMed ID: 16413394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombopoietin and the c-Mpl receptor: insights from gene targeting.
    Alexander WS
    Int J Biochem Cell Biol; 1999 Oct; 31(10):1027-35. PubMed ID: 10582337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional roles of thrombopoietin-c-mpl system in essential thrombocythemia.
    Matsumura I; Horikawa Y; Kanakura Y
    Leuk Lymphoma; 1999 Jan; 32(3-4):351-8. PubMed ID: 10037033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.